During the past decade, Hospital General de Lanzarote conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital General de Lanzarote" are "Multiple Myeloma" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials) and "Acute Promyelocytic Leukemia" (1 trials). Many other conditions were trialed in "Hospital General de Lanzarote" in a lesser frequency.

Most popular intervention types in "Hospital General de Lanzarote" are "Drug" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "ATRA" (1 trials), "Allogenic Transplantation" (1 trials), "Arsenic Trioxide" (1 trials), "Asparaginase" (1 trials) and "Autologous Transplantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General de Lanzarote" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hospital General de Lanzarote". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital General de Lanzarote, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General de Lanzarote, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".